The New York Islanders’ Monday practice was laden with positive injury updates, including the brief return of Pierre Engvall, Alexander Romanov, and Sergei Varlamov at various points around practice. Even with the positives, New York will need to adjust their lineup, as winger Max Shabanov recovers from a day-to-day, lower-body injury per NHL.com’s Stefen Rosner.

The Islanders iced depth winger Kyle MacLean and listed Shabanov as a healthy scratch in Saturday’s win over the Calgary Flames. MacLean contributed one assist to the Islanders’ three-goal effort. That brought him up to seven points in 48 games this season. MacLean has spent many of those games in a fourth-line role that should continue on until Shabanov returns to a lineup role. New York could also lean on Marc Gatcomb, who has scored four points in 36 games this season.

Shabanov has had a tough time transitioning to the NHL after a standout season in Russia’s KHL last season. He finished the 2024-25 season with 23 goals and 67 points in 65 KHL games, the third-most points in the league. That production made Shabanov a top free agent last summer. Multiple teams were in on the race to sign the stickhandling wizard, with the Islanders ultimately winning out.

New York began the season with Shabanov in a middle-six role. He scored 10 points in his first 19 NHL games, while averaging just over 14 minutes a game. That hot streak was followed by a nine-game stretch where Shabanov only scored one point, beginning in mid-December. He kicked the bug for a bit, only to fall into another cold streak recently, with one point in his last 12 games.

The Islanders have responded to the dwindling scoring by demoting Shabanov to a fourth-line role and even healthy scratching the scoring winger. He sits with four goals and 16 points in 42 games in his NHL rookie season. A short-term injury will offer Shabanov a chance to rest up after a tough stretch and prepare to once again contribute strong scoring as the Islanders push for their first playoff appearance since 2024.

View Comments (0)